Immuneering

Immuneering IMRX Stock

$3.46   -1.704540%
Add to favorites
Market Cap
$224.08M
LOW - HIGH [24H]
$3.31 - $3.63
VOLUME [24H]
$1.25M
P/E Ratio
0
Earnings per share
-$0.92
ISIN
US45254E1073
Price   Prediction

Immuneering Price Chart

Sorry, that's all we've gotfor now...

Immuneering (IMRX) stock price today is 3.46 USD on Tech Market Middle (-1.7% on the day). Updated .

Immuneering IMRX Financial and Trading Overview

Immuneering stock price 3.46 USD
Previous Close 3.71 USD
Open 3.7 USD
Bid 3.22 USD x 200
Ask 5.52 USD x 200
Day's Range 3.48 - 3.78 USD
52 Week Range 3.35 - 8.48 USD
Volume 1.02M USD
Avg. Volume 709.55K USD
Market Cap 227.97M USD
Beta (5Y Monthly) 0.459
PE Ratio (TTM) N/A
EPS (TTM) -0.92 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 17 USD

IMRX Valuation Measures

Enterprise Value 86.1M USD
Trailing P/E N/A
Forward P/E -2.1444716
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 1.3512475
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.171

Trading Information

Immuneering Stock Price History

Beta (5Y Monthly) 0.459
52-Week Change -46.38%
S&P500 52-Week Change 13.32%
52 Week High 8.48 USD
52 Week Low 3.35 USD
50-Day Moving Average 4 USD
200-Day Moving Average 4.74 USD

IMRX Share Statistics

Avg. Volume (3 month) 709.55K USD
Avg. Daily Volume (10-Days) 725.54K USD
Shares Outstanding 64.76M
Float 49.28M
Short Ratio 18.69
% Held by Insiders 14.23%
% Held by Institutions 58.03%
Shares Short 14.6M
Short % of Float 29.69%
Short % of Shares Outstanding 22.54%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -21.79%
Return on Equity (ttm) -33.53%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -73519040 USD
Net Income Avi to Common (ttm) -66503916 USD
Diluted EPS (ttm) -0.87
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 145.41M USD
Total Cash Per Share (mrq) 2.25 USD
Total Debt (mrq) 3.53M USD
Total Debt/Equity (mrq) 2.1 USD
Current Ratio (mrq) 13.966
Book Value Per Share (mrq) 2.605

Cash Flow Statement

Operating Cash Flow (ttm) -61560688 USD
Levered Free Cash Flow (ttm) -41682548 USD

Profile of Immuneering

Country United States
State MA
City Cambridge
Address 245 Main Street
ZIP 02142
Phone 617 500 8080
Website https://immuneering.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 65

Immuneering Corporation, a late-stage oncology company, develops medicines for broad populations of cancer patients in the United States. The company develops IMM-1-104 (atebimetinib), a dual-MEK inhibitor that is in a Phase 3 clinical trial to treat patients with cancer, including pancreatic and non-small cell lung cancer caused by mutations of RAS or RAF; IMM-6-415 (envometinib), which is in Phase 1/2a clinical trial for the treatment of patients with solid tumors; and multiple deep cyclic inhibitor discovery programs. The company has clinical supply agreements with Regeneron Pharmaceuticals to evaluate atebimetinib in combination with Libtayo in patients with unresectable or metastatic RAS-mutant non-small cell lung cancer; and with Eli Lilly and Company to evaluate atebimetinib in combination with olomorasib in patients with advanced or metastatic KRAS G12C-mutant non-small cell lung cancer. Immuneering Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Q&A For Immuneering Stock

What is a current IMRX stock price?

Immuneering IMRX stock price today per share is 3.46 USD.

How to purchase Immuneering stock?

You can buy IMRX shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Immuneering?

The stock symbol or ticker of Immuneering is IMRX.

Which industry does the Immuneering company belong to?

The Immuneering industry is Biotechnology.

How many shares does Immuneering have in circulation?

The max supply of Immuneering shares is 64.76M.

What is Immuneering Price to Earnings Ratio (PE Ratio)?

Immuneering PE Ratio is now.

What was Immuneering earnings per share over the trailing 12 months (TTM)?

Immuneering EPS is -0.92 USD over the trailing 12 months.

Which sector does the Immuneering company belong to?

The Immuneering sector is Healthcare.

Immuneering IMRX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 24328.38 USD —
-0.74
8.59B USD — 23989.09 USD — 24547.66 USD — — 8.59B USD —
us US Tech Global Market Composite NQGM US 1835.7 USD —
-1.77
— — 1816.36 USD — 1866.76 USD — — — —
us US Tech Biotechnology NBI US 7017.81 USD —
-0.71
— — 6949.3 USD — 7058.02 USD — — — —
us US Tech Health Care IXHC US 1332.89 USD —
-0.73
— — 1323.81 USD — 1342.94 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.18T
Total marketcap
$72.01B
Total volume
BTC 59.04%   •   ETH 10.04%
Dominance
Select currency